How Shaw was paid
$1.2M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Other | Total |
|---|---|---|---|
| Thomas J. ShawPresident and CEO | $1,211,545 | $10,500 | $1,222,045 |
| Michele M. LariosVice President, General Counsel | $400,000 | $10,500 | $410,500 |
| John W. Fort IIIVice President, CFO | $300,000 | $9,992 | $309,992 |
| Kathryn M. DuesmanVice President of Clinical Affairs | $198,406 | $4,973 | $203,879 |
| Kevin McGlincheyVice President of Domestic Sales Development | $275,000 | $16,953 | $292,453 |
What changed and why
- $1.2MThomas J. Shaw received a total compensation of $1,222,045 for fiscal 2025, representing an increase from the prior year.
- Base salary makes up the primary component of executive compensation because the company weighs its program heavily toward base salaries.
- No stock option awards or annual cash bonuses were granted to the named executive officers for fiscal 2025.
- The pay ratio of the principal executive officer to the median employee's annual total compensation was 32.34 to 1.
- Executive compensation is based on historical performance and individual contribution rather than quantitative corporate financial performance metrics.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.